Accordingly, the activation of oxytocin receptor has been found to elevate the invasive properties of endometrial cancer cells via the PI3K/Akt axis [32] and to promote the migratory ability of prostate cancer cells by coupling to the Gi-dependent pathway [33]. The gene discussed is GNAI1; the disease is prostate carcinoma.